Condition guide
Vaginal Yeast Infection: Symptoms, OTC Treatment & Testing
Vaginal candidiasis symptoms, OTC azole treatments, recurrent or complicated infections, diagnostic uncertainty and when medical care is appropriate.
Bottom line
Uncomplicated vulvovaginal candidiasis can often be treated with appropriately labeled intravaginal azole products such as clotrimazole or miconazole, but vaginal itching and discharge are not specific to yeast. First episodes, recurrent symptoms, pregnancy, severe symptoms and treatment failure deserve diagnostic attention.
Compare products here
Products associated with Vaginal Yeast Infection: Symptoms, OTC Treatment & Testing
Start with the facts that actually change the choice: active ingredient, strength, vehicle, label scope and the main tradeoff. No ranking is implied.
16 products
12 brands
8 active profiles
Format mix
| Product | Active / strength | Vehicle | Label scope | What stands out |
|---|---|---|---|---|
| Lamisil AT Cream: Terbinafine Hydrochloride 1%Lamisil | Terbinafine hydrochloride1% | Cream | Most athlete's foot, jock itch and ringworm | The labeled treatment duration varies by infection location, and the skin cream should not be generalized to nail or mucosal infections. |
| Lotrimin Clotrimazole Cream 1%Lotrimin | Clotrimazole1% | Cream | Most athlete's foot, jock itch and ringworm | Its broad skin-fungus labeling is useful, but treatment courses are longer than some terbinafine or butenafine regimens and product labeling should control. |
| Lotrimin Ultra Butenafine Hydrochloride Cream 1%Lotrimin | Butenafine hydrochloride1% | Cream | Most athlete's foot between the toes; label states effectiveness on bottom or sides of foot is unknown | The label supports a relatively short interdigital athlete's-foot regimen but is unusually explicit about uncertainty for other foot locations. |
| Tinactin Tolnaftate Cream 1%Tinactin | Tolnaftate1% | Cream | Most athlete's foot and ringworm; helps prevent most athlete's foot with daily use | The current cited cream label includes athlete's-foot prevention language, but its listed treatment indications are narrower than some multi-condition azole or terbinafine creams. |
| Monistat 7 Miconazole Nitrate Vaginal Cream 2%Monistat | Miconazole nitrate2% | Vaginal cream with disposable applicators | Treats vaginal yeast infections and relieves associated external itching/irritation | The longer seven-day regimen uses a lower-concentration miconazole cream and has a distinct body-site label; it should not be compared as though it were interchangeable with external skin antifungal creams. |
| Nystatin Oral Suspension 100,000 units/mL — Oral Thrush ReferenceGeneric nystatin | Nystatin | Oral suspension | See fact sheet | Repeated mouth dosing and local action versus systemic azole therapy. |
| Clotrimazole Troche 10 mg — Oral Thrush Antifungal ReferenceGeneric clotrimazole | Clotrimazole | Troche / slowly dissolving oral lozenge | See fact sheet | Local oral exposure requires repeated slowly dissolved doses. |
| Fluconazole Tablets — Candidiasis Prescription ReferenceGeneric fluconazole | Fluconazole | Oral tablet | See fact sheet | Systemic reach versus broader interaction, hepatic, QT and pregnancy considerations. |
| Lotrimin AF Miconazole Nitrate Powder Spray 2%Lotrimin | Miconazole nitrate2% | Talc-free aerosol powder spray | Most athlete's foot; relieves itching, burning, cracking and scaling | The aerosol format goes on dry but adds flammability and pressurized-container warnings that creams do not have. |
| Tinactin Tolnaftate Powder Spray 1%Tinactin | Tolnaftate1% | Aerosol powder spray | Most athlete's foot and ringworm; helps prevent most athlete's foot with daily use | The dry aerosol is convenient for feet and footwear-adjacent routines but introduces flammability and inhalation-misuse warnings. |
| Tinactin Jock Itch Tolnaftate Powder Spray 1%Tinactin | Tolnaftate1% | Aerosol powder spray | Most jock itch | The active matches other tolnaftate products, but the labeled indication and course are formulation/SKU specific, reinforcing why brand-level comparisons are not enough. |
| Walgreens Free+Pure Athlete's Foot Liquid Spray — Miconazole 2%Walgreens | Miconazole nitrate2% | Liquid aerosol spray | Most athlete's foot, ringworm and jock itch | The spray format avoids rubbing in a cream but adds flammability, pressurized-container and inhalation-misuse warnings. |
| ARM & HAMMER Medicated Athlete's Foot Powder — Miconazole 2%ARM & HAMMER | Miconazole nitrate2% | Loose topical powder | Most athlete's foot, jock itch and ringworm | The loose-powder vehicle avoids aerosol handling warnings but uses the longer miconazole-labeled treatment courses and requires powder application. |
| Equate Tioconazole 1 Day — Tioconazole 6.5% Vaginal OintmentEquate | Tioconazole6.5% (300 mg per applicator) | Vaginal ointment in prefilled applicator | Treats vaginal yeast infections | One-dose describes the administration schedule, not guaranteed symptom resolution in one day; the label says complete relief can take up to 7 days. |
| Miconazole 1 Yeast Infection Relief — 1200 mg Insert + 2% External CreamStore-brand Miconazole 1 | Miconazole nitrate1200 mg vaginal insert + 2% external cream | One-dose vaginal insert + external cream | Treats vaginal yeast infection; external cream relieves associated external itching/irritation | The vaginal insert is one dose, but the label notes symptom relief can take several days and the external cream may be used twice daily for up to 7 days. |
| Kroger Miconazole 3 — 200 mg Suppositories + 2% External CreamKroger | Miconazole nitrate200 mg per vaginal suppository + 2% external cream | Three vaginal suppositories + external cream | Treats vaginal yeast infection; external cream relieves associated external itching/irritation | This uses three nightly vaginal doses rather than one or seven; regimen length should not be treated as a simple potency ranking. |
LamisilCream
Lamisil AT Cream: Terbinafine Hydrochloride 1%
- Active
- Terbinafine hydrochloride · 1%
- Label scope
- Most athlete's foot, jock itch and ringworm
- Tradeoff
- The labeled treatment duration varies by infection location, and the skin cream should not be generalized to nail or mucosal infections.
LotriminCream
Lotrimin Clotrimazole Cream 1%
- Active
- Clotrimazole · 1%
- Label scope
- Most athlete's foot, jock itch and ringworm
- Tradeoff
- Its broad skin-fungus labeling is useful, but treatment courses are longer than some terbinafine or butenafine regimens and product labeling should control.
LotriminCream
Lotrimin Ultra Butenafine Hydrochloride Cream 1%
- Active
- Butenafine hydrochloride · 1%
- Label scope
- Most athlete's foot between the toes; label states effectiveness on bottom or sides of foot is unknown
- Tradeoff
- The label supports a relatively short interdigital athlete's-foot regimen but is unusually explicit about uncertainty for other foot locations.
TinactinCream
Tinactin Tolnaftate Cream 1%
- Active
- Tolnaftate · 1%
- Label scope
- Most athlete's foot and ringworm; helps prevent most athlete's foot with daily use
- Tradeoff
- The current cited cream label includes athlete's-foot prevention language, but its listed treatment indications are narrower than some multi-condition azole or terbinafine creams.
MonistatVaginal cream with disposable applicators
Monistat 7 Miconazole Nitrate Vaginal Cream 2%
- Active
- Miconazole nitrate · 2%
- Label scope
- Treats vaginal yeast infections and relieves associated external itching/irritation
- Tradeoff
- The longer seven-day regimen uses a lower-concentration miconazole cream and has a distinct body-site label; it should not be compared as though it were interchangeable with external skin antifungal creams.
Generic nystatinOral suspension
Nystatin Oral Suspension 100,000 units/mL — Oral Thrush Reference
- Active
- Nystatin
- Label scope
- See fact sheet
- Tradeoff
- Repeated mouth dosing and local action versus systemic azole therapy.
Generic clotrimazoleTroche / slowly dissolving oral lozenge
Clotrimazole Troche 10 mg — Oral Thrush Antifungal Reference
- Active
- Clotrimazole
- Label scope
- See fact sheet
- Tradeoff
- Local oral exposure requires repeated slowly dissolved doses.
Generic fluconazoleOral tablet
Fluconazole Tablets — Candidiasis Prescription Reference
- Active
- Fluconazole
- Label scope
- See fact sheet
- Tradeoff
- Systemic reach versus broader interaction, hepatic, QT and pregnancy considerations.
LotriminTalc-free aerosol powder spray
Lotrimin AF Miconazole Nitrate Powder Spray 2%
- Active
- Miconazole nitrate · 2%
- Label scope
- Most athlete's foot; relieves itching, burning, cracking and scaling
- Tradeoff
- The aerosol format goes on dry but adds flammability and pressurized-container warnings that creams do not have.
TinactinAerosol powder spray
Tinactin Tolnaftate Powder Spray 1%
- Active
- Tolnaftate · 1%
- Label scope
- Most athlete's foot and ringworm; helps prevent most athlete's foot with daily use
- Tradeoff
- The dry aerosol is convenient for feet and footwear-adjacent routines but introduces flammability and inhalation-misuse warnings.
TinactinAerosol powder spray
Tinactin Jock Itch Tolnaftate Powder Spray 1%
- Active
- Tolnaftate · 1%
- Label scope
- Most jock itch
- Tradeoff
- The active matches other tolnaftate products, but the labeled indication and course are formulation/SKU specific, reinforcing why brand-level comparisons are not enough.
WalgreensLiquid aerosol spray
Walgreens Free+Pure Athlete's Foot Liquid Spray — Miconazole 2%
- Active
- Miconazole nitrate · 2%
- Label scope
- Most athlete's foot, ringworm and jock itch
- Tradeoff
- The spray format avoids rubbing in a cream but adds flammability, pressurized-container and inhalation-misuse warnings.
ARM & HAMMERLoose topical powder
ARM & HAMMER Medicated Athlete's Foot Powder — Miconazole 2%
- Active
- Miconazole nitrate · 2%
- Label scope
- Most athlete's foot, jock itch and ringworm
- Tradeoff
- The loose-powder vehicle avoids aerosol handling warnings but uses the longer miconazole-labeled treatment courses and requires powder application.
EquateVaginal ointment in prefilled applicator
Equate Tioconazole 1 Day — Tioconazole 6.5% Vaginal Ointment
- Active
- Tioconazole · 6.5% (300 mg per applicator)
- Label scope
- Treats vaginal yeast infections
- Tradeoff
- One-dose describes the administration schedule, not guaranteed symptom resolution in one day; the label says complete relief can take up to 7 days.
Store-brand Miconazole 1One-dose vaginal insert + external cream
Miconazole 1 Yeast Infection Relief — 1200 mg Insert + 2% External Cream
- Active
- Miconazole nitrate · 1200 mg vaginal insert + 2% external cream
- Label scope
- Treats vaginal yeast infection; external cream relieves associated external itching/irritation
- Tradeoff
- The vaginal insert is one dose, but the label notes symptom relief can take several days and the external cream may be used twice daily for up to 7 days.
KrogerThree vaginal suppositories + external cream
Kroger Miconazole 3 — 200 mg Suppositories + 2% External Cream
- Active
- Miconazole nitrate · 200 mg per vaginal suppository + 2% external cream
- Label scope
- Treats vaginal yeast infection; external cream relieves associated external itching/irritation
- Tradeoff
- This uses three nightly vaginal doses rather than one or seven; regimen length should not be treated as a simple potency ranking.
Understand the condition
Treatment context, evidence and practical next steps
The comparison above is a product map, not a diagnosis or a substitute for treatment guidance. Use the evidence below to understand where those products fit—and where they do not.
Symptoms overlap with other vaginal conditions
Typical symptoms of vulvovaginal candidiasis can include itching, soreness, external burning with urination, pain with sex and abnormal discharge. CDC emphasizes that none of these symptoms is specific enough to prove Candida by itself.
Repeated self-treatment without improvement is a reason to confirm the diagnosis rather than simply trying another yeast product.
OTC treatment options
CDC treatment guidelines list several over-the-counter intravaginal azole regimens for uncomplicated candidiasis, including clotrimazole, miconazole and tioconazole formulations. Course lengths differ by concentration and product.
Compare OTC products by:
- active ingredient;
- formulation and dose;
- treatment duration;
- whether the product is labeled for internal vaginal use;
- individual allergy or irritation history.
Comparing products? Use the 1-day vs 3-day vs 7-day OTC vaginal antifungal comparison to align active ingredient, dose, formulation, directions, age limits and major label warnings. The day count describes the dosing schedule—not a universal potency ranking.
When candidiasis is considered complicated
CDC distinguishes uncomplicated cases from severe, recurrent, non-albicans or host-complicated candidiasis. Diabetes, immune suppression and recurrent disease can shift the treatment approach and increase the value of testing.
Recurrent symptoms need a diagnosis
Persistent symptoms after OTC treatment do not automatically mean ‘resistant yeast.’ The original diagnosis may have been wrong, the organism may be a less common Candida species, or another vaginal condition may be present.
Pregnancy and prescription treatment
Pregnancy changes medication choices. Do not assume that an oral prescription commonly used outside pregnancy is appropriate during pregnancy; use clinician guidance.
When to seek care
Seek medical evaluation for a first uncertain episode, pregnancy, frequent recurrence, severe swelling or fissuring, fever or pelvic pain, unusual discharge/odor, STI concern, or symptoms that persist or return after treatment.
See fungal infections for how Candida differs from dermatophyte infections such as athlete’s foot and ringworm.
Primary references
- CDC STI Treatment Guidelines, Vulvovaginal Candidiasis: https://www.cdc.gov/std/treatment-guidelines/candidiasis.htm
- CDC, Treatment of candidiasis: https://www.cdc.gov/candidiasis/treatment/index.html
Source trail
Primary documents and supporting evidence
- Vulvovaginal Candidiasis - STI Treatment GuidelinesCenters for Disease Control and Prevention · Clinical guideline · retrieved 2026-08-11
- Treatment of CandidiasisCenters for Disease Control and Prevention · Government health · retrieved 2026-08-11